LIPOSOME COMPOSITION FOR REDUCTION OF LIPOSOME-INDUCED COMPLEMENT ACTIVATION

摘要

A method for reducing complement activation upon in vivo administration of a liposome preparation containing an entrapped therapeutic agent is described. The method involves providing liposomes having a polyethylene-glycol-derived neutral lipopolymer.